Hainan Poly Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HAINAN POLY PHARM, and what generic and branded alternatives to HAINAN POLY PHARM drugs are available?
HAINAN POLY PHARM has six approved drugs.
Drugs and US Patents for Hainan Poly Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hainan Poly Pharm | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | INJECTABLE;INJECTION | 212332-001 | Jun 12, 2019 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hainan Poly Pharm | DAPTOMYCIN | daptomycin | POWDER;INTRAVENOUS | 215890-001 | Aug 18, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hainan Poly Pharm | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | INJECTABLE;INJECTION | 212332-002 | Jun 12, 2019 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hainan Poly Pharm | LEVOLEUCOVORIN CALCIUM | levoleucovorin calcium | SOLUTION;INTRAVENOUS | 217314-001 | May 22, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hainan Poly Pharm | LEVOLEUCOVORIN CALCIUM | levoleucovorin calcium | SOLUTION;INTRAVENOUS | 217314-002 | May 22, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hainan Poly Pharm | GADOBUTROL | gadobutrol | SOLUTION;INTRAVENOUS | 217480-002 | Mar 15, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.